Mercury Biomed

Mercury Biomed is commercializing novel and proprietary technology to safely and effectively adjust and maintain a patient’s core body temperature. Its WarmSmart and SmartCool products are currently in clinical trials and are targeted for launch in 2016 and 2018, respectively, pending FDA 510 (k) clearances.

Stage: Clinical

News: Mercury Biomed Awarded NIH Grant